MAPT and Alzheimer disease: Deregulated expression of miRNAs may contribute to the regulation of key genes involved in AD, including amyloid production [116,117,148,149,150] and tau regulation [121,123,151], although it remains to be elucidated whether the correlation between the levels of miRNA expression and AD pathology is a cause or a consequence of the disease.